• Home
  • News

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

genetic technologies logo

Press Release – New York, NY – May 28, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a public offering of 4,000,000 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.